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Abstract
BACKGROUND: Imaging biomarkers, such as the T1 relaxation time of the myocardium 
using MRI, can be valuable in cardiac medicine if they are properly validated. Consensus 
statements recommend that for myocardial T1, each investigator should establish a reference 
range. 
PURPOSE: To describe a statistically valid method for determining and reporting the 
reference range in each center, which simultaneously minimizes the twin risks of 
undersampling, leading to a uselessly uncertain range, and oversampling, which exposes 
volunteers to unnecessary scanning and wastes resources.
STUDY TYPE: Cohort
POPULATION: 278 normal human subjects without cardiac disease from two cardiac MR 
centers.
FIELD STRENGTH/SEQUENCE: 1.5T and 3T; Modified Look-Locker Inversion recovery 
sequence
ASSESSMENT: n/a The T1 relaxation time was estimated from multiple samples of tissue 
magnetization after inversion. A valid method for calculating a reference range is used.
STATISTICAL TESTS: Shapiro-Wilk test for Normality; Tukey robust approach for 
identification of outliers; reference range calculation with confidence intervals.
RESULTS: Reference ranges for measurement of myocardial T1 were calculated, with 
confidence intervals, enabling comparison with clinically important differences. At 3.0T: 
1129 to 1301 ms at site 1 (n=21) and 1160 to 1309 ms at site 2 (n=59), and at 1.5T at site 2: 
933 to 1020 ms (male, n=130) and 965 to 1054 ms (female, n=68). The 3T reference range 
from site 1 was successfully benchmarked against the 3T reference range at site 2.
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DATA CONCLUSION: Myocardial T1 reference ranges can be properly characterized, 
enabling clinical comparison to a valid reference range with known confidence intervals, 
using methodology similar to that described in this report.
Keywords
Imaging biomarker, T1 mapping, reference range, reference interval, normal values
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INTRODUCTION
Imaging biomarkers play an increasing role in cardiac medicine.  The BEST Resource (1) 
from the FDA–NIH Biomarker Working Group defines a biomarker as “a defined 
characteristic that is measured as an indicator of normal biological processes, pathogenic 
processes, or responses to an exposure or intervention, including therapeutic interventions”. It 
continues “…molecular, histologic, radiographic, or physiologic characteristics are types of 
biomarkers”,  making imaging biomarkers such as the MR T1 relaxation time of the 
myocardium, if validated, formally equivalent to blood-borne molecular biomarkers such as 
troponin T and LDL-cholesterol, or to physiologic biomarkers such as systolic blood 
pressure. 
A biomarker measured in similar patients with different equipment in different hospitals 
should yield similar values (2). This is an essential prerequisite before embarking on large 
multicenter outcome studies to create an evidence base for use.  Unfortunately, for 
myocardial T1, this basic technical validation step is rather challenging. The design and 
operation of different manufacturers’ MR equipment may affect accuracy, and in the case of 
myocardial fibrosis, even quite small differences in T1 may be biologically important. 
Recognising this risk of between-center irreproducibility, consensus statements recommend 
that each investigator should establish a reference range for myocardial T1 for his or her own 
equipment (3, 4).
A study to fully define the reference range involves a considerable number of subjects and 
significant costs – particularly if it has to be replicated by every investigator and for every 
new scanner installation or upgrade. More importantly it poses an ethical challenge: How best 
to define an adequate reference range while minimizing the exposure of volunteers to the 
burden of MR scanning from which they gain no benefit.
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The purpose of this work is to provide statistically valid methodology for investigators to 
calculate and interpret a reference range in their centre, while minimizing the twin risks of 
undersampling, leading to a uselessly uncertain range, and oversampling, which exposes 
volunteers to unnecessary scanning and wastes resources. Related tasks are also addressed, 
such as predicting the number of subjects needed, dealing with outliers, and benchmarking 
one reference range against another. Myocardial T1 reference ranges are reported. With the 
recent availability of mapping-based myocardial tissue characterization on clinical magnetic 
resonance systems, mapping of the T1 relaxation time is an exemplar imaging biomarker, but 
our approach is general.
METHODS
Data acquired for this work was acquired at site 1 using a healthy volunteer database (each 
subject provided informed consent and the study was approved by the local Ethics Review 
Board), and from site 2 using data from the local T1 quality control collective (aggregate data 
used for service evaluation does not require further ethical review (decision of the local 
Ethical Review Board)).
The calculation of four myocardial T1 reference ranges of subjects without cardiac disease is 
reported here: a 3T reference range which includes both male and female subjects from site 1 
(n=21, 5 male and 16 female, with age mean/sd 57/12y); a 3T reference range which includes 
both male and female subjects from site 2 (n=59, 38 male and 21 female, with age mean/sd 
52/9y); 1.5T reference range for males at site 2 (n=132 with age mean/sd 50/8 y); and a 1.5T 
reference range for females at site 2 (n=68 with age mean/sd 48/10 y). Site 1 used a single 
Achieva TX MR system (Philips, Best, The Netherlands) using patient-adaptive RF 
shimming and a 6 channel receiver array. Site 2 used Ingenia MR systems (Philips, Best, The 
Netherlands) at both 1.5T and 3.0T, both using a 28 channel receiver array. All acquisitions 
Page 5 of 56
Journal of Magnetic Resonance Imaging
Journal of Magnetic Resonance Imaging
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
FO
R PEER REVIEW
 O
N
LY
Page 6
employed a MOLLI 5s(3s)3s product sequence (breath hold duration 11 seconds not 
dependent on heart rate). At 3.0T, sequence parameters include: acquired voxel size 
2.0x2.0mm; TR/TE/flip angle 2.2ms/0.92ms/20°; SENSE acceleration factor 2, partial 
Fourier factors kx/ky 0.63/0.85; receiver bandwidth 1086 Hz/px; acquisition in end-systole 
(site 1) and end-diastole (site 2). At 1.5T, sequence parameters include: acquired voxel size 
2.0x2.0mm; TR/TE/flip angle 2.4ms/1.1ms/35°; SENSE acceleration factor 2, partial Fourier 
factors kx/ky 0.63/0.85; receiver bandwidth 1082 Hz/px; acquisition in end-diastole. No 
motion correction was applied and MOLLI source images were checked to ensure a steady 
breath hold position and myocardium alignment between source images. In cases of poor 
breath holding, the slice/map was reacquired. A blood correction was not applied. ROIs over 
the whole left ventricle myocardium were used at site 1 and over a left ventricle myocardium 
of a mid-slice at site 2.
The Shapiro-Wilk test was employed to provide evidence that sample data are likely drawn 
from a Normally distributed population. Outliers are identified using the Tukey robust 
approach with box-and-whisker plots displaying interquartile ranges (IQR: Q3-Q1; Q1: lower 
quartile, Q3: upper quartile); at levels of < Q1 - 1.5 IQR and / or > Q3 + 1.5 IQR, the outliers 
are discarded (5, 6).
An ordered list of calculations which can be used to create a reference range is presented in 
Table 1. To facilitate the reader, various commands are identified for Microsoft Excel (2010 
or later) and Google Sheets. Confidence intervals (CIs) are used to indicate a probability that 
values calculated from a random sample will include the population value of interest. 
Calculated values are labelled in Table 1 and correspond to labels in Figure 1.
Thus, referring to Figure 1 and Table 1:
• the 95% reference range is from J to H
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• the 90% confidence intervals around the reference range limits are R to Q, and P to N
• the mean value is A with a 90% confidence interval of U to T.
RESULTS
Site 1 at 3.0T Males and Females
Whole-heart ROI T1 data at 3 tesla for 21 normal subjects are listed here to allow repetition 
of calculations by the reader and were: 1245, 1243, 1299, 1261, 1243, 1245, 1144, 1224, 
1133, 1186, 1179, 1213, 1202, 1244, 1220, 1174, 1212, 1211, 1157, 1233, 1245 ms. Visual 
inspection of the data using a box-and-whisker plot confirmed no outliers are present (see 
Figure 2).
Using the Shapiro-Wilk test, the calculated W statistic was 0.96, higher than the critical value 
of W of 0.91 (significance level 0.05), therefore the null hypothesis that the data are 
Normally distributed was not rejected. The data are likely consistent with the Normal 
distribution.
The 95% reference range is 1215 ± 86 ms. I.e. the 95% reference range is 1129 to 1301 ms.
The 90% CIs around the reference range limits are 1102 to 1156 ms and 1274 to 1328 ms. 
These 90% CIs around the reference range limits each are 32% of the reference range size.
The confidence intervals around the reference range limits allow us to state with increased 
confidence that a patient’s T1 value is outside the reference range for the population, if it is 
outside the range from the lower CI boundary of the lower end of the reference range to the 
upper CI boundary of the upper end of the reference range (i.e. R to N in Figure 1). For this 
data set this corresponds to values less than 1102 and more than 1328 ms. 
The mean T1 in the normal subjects was 1215 ms with a 90% confidence interval of 1199 to 
1230 ms (note that this is not the reference range).
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Site 2 at 3.0T Males and Females
The box-and-whisker plot confirmed no outliers are present (see Figure 2).
Using the Shapiro-Wilk test, the calculated W statistic was 0.99, higher than the critical value 
of W of 0.96 (significance level 0.05), therefore the null hypothesis that the data are 
Normally distributed was not rejected. The data are likely consistent with the Normal 
distribution.
The 95% reference range is 1234 ± 75 ms. I.e., the 95% reference range is 1160 to 1309 ms.
The 90% CIs around the reference range limits are 1145 to 1174 ms and 1295 to 1323 ms. 
These 90% CIs around the reference range limits each are 19% of the reference range size.
The range outside of which data may be more confidently placed outside the reference range 
for the population (i.e. R to N in Figure 1) for this data set this corresponds to 1145 to 
1323 ms. 
The mean T1 in the normal subjects was 1234 ms with a 90% confidence interval of 1226 to 
1242 ms (note that this is not the reference range).
Site 2 at 1.5T Males
The box-and-whisker plots showed two outliers present (see Figure 3). Upon clinical review 
of the outlier subjects, the high-T1 outlier was excluded due to clinical confounders. Using 
the Tukey robust approach described above it was confirmed that both outliers were outside 
the range for excluding unexplained outliers for this data (920-1034ms), and therefore the 
low-T1 outlier was also omitted from the following results (i.e. updated n = 130).
Using the Shapiro-Wilk test, the calculated W statistic for the male T1 data is 0.99, higher 
than the critical value of W of 0.98 (significance level 0.05). Therefore, the null hypothesis 
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that the data are Normally distributed was not rejected. The data are likely consistent with the 
Normal distribution.
The 95% reference range is 976 ± 44 ms. I.e., the 95% reference range is 933 to 1020 ms.
The 90% CIs around the reference range limits are 927 to 938 ms and 1014 to 1025 ms. 
These 90% CIs around the reference range limits each are 13% of the reference range size.
The range outside of which data may be more confidently placed outside the reference range 
for the population (i.e. R to N in Figure 1) for this data set this corresponds to 927 to 
1025 ms. 
The mean T1 in the normal subjects was 976 ms with a 90% confidence interval of 973 to 
979 ms (note this is not the reference range).
Site 2 at 1.5T Females
The box-and-whisker plot confirmed no outliers are present (see Figure 3).
Using the Shapiro-Wilk test, the calculated W statistic for female T1 data is 0.97, higher than 
the critical value of W of 0.96 (significance level 0.05). Therefore the null hypothesis that the 
data are Normally distributed was not rejected. The data are likely consistent with the Normal 
distribution.
The 95% reference range is 1009 ± 44 ms. I.e., the 95% reference range is 965 to 1054 ms.
The 90% CIs around the reference range limits are 957 to 973 ms and 1046 to 1061 ms. 
These 90% CIs around the reference range limits each are 18% of the reference range size.
The range outside of which data may be more confidently placed outside the reference range 
for the population (i.e. R to N in Figure 1) for this data set this corresponds to 957 to 
1061 ms. 
Page 9 of 56
Journal of Magnetic Resonance Imaging
Journal of Magnetic Resonance Imaging
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
FO
R PEER REVIEW
 O
N
LY
Page 10
The mean T1 in the normal subjects was 1009 ms with a 90% confidence interval of 1005 to 
1014 ms (note this is not the reference range).
Comparison of the reference ranges can be made with Table 2.
DISCUSSION
Thorough technical validation of an imaging biomarker includes assessment of whether the 
imaging biomarker measurement can be utilised in any geographical location and give 
comparable data (2). This requires an understanding of its repeatability (over measurements 
performed multiple times in the same subject using the same equipment, software and 
operators over a short timeframe), reproducibility (over measurements performed using 
different equipment, different software or operators, or at different sites and times, either in 
the same or in different subjects), and bias (systematic difference between measurements of a 
parameter and its real value). Even after minimizing all confounding technical and 
physiological pitfalls that influence the myocardial T1 (7), high quality reference ranges are 
still required to inform studies establishing clinical utility. The calculations and discussion 
provided in this work will enable clinical researchers using myocardial T1 measurement to 
create a robust local reference range and apply it carefully. It is not the intention of this work 
to review published data of myocardial T1 values; such reviews may be found in the 
literature (8). Nor is it proposed that the reference ranges reported in this work are ideal. 
Variations in workflow for any range may change utility, e.g., variations in pulse sequence 
used, whether motion correction is applied, how ROIs are placed including choice of 
segmentation, imaging in systole or diastole, subgroup analysis by gender or application of 
blood correction, et cetera. Rather, they illustrate that, whatever the end-to-end workflow of 
data acquisition and analysis, any reference range can be properly characterised and its utility 
more clearly understood, enabling appropriate use of a reference range in the clinical setting. 
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The increased precision of the reference range limits can be appreciated with a larger number 
of subjects in our 3.0T data from two sites. 
We use the term “reference range”, outside of which T1 would be suspected to be abnormal, 
possibly affecting patient treatment. This term is equivalent to “reference interval”; we avoid 
the alternative term “normal range” as it may be confused with the Normal distribution. The 
reference population should be as similar as possible to the population on which the reference 
range will be applied. In some settings it may be necessary for a subgroup, such as 
older/younger age or male/female gender, to be considered with its own reference range; 
statistical criteria have been described for biochemical biomarkers which can identify such 
groups by focusing on the proportions of the subgroups outside the reference-range limits of 
the entire population (5). Whether subgroups are required will also depend on the effect size 
of the T1 change in disease. Subgroup reference ranges should not, however, be calculated 
unless there is a strong statistical rationale, as this increases the total required number of 
healthy participants, which must be counted separately in each subgroup. 
For myocardial T1, data acquisition methods require attention. For example, in the case of 
Modified Look-Locker Imaging (MOLLI) T1 mapping methods as used in this work, 
particular attention should be paid to the MOLLI scheme; there are significant improvements 
in the performance of newer schemes as used in cardiac T1 mapping product software such as 
5s(3s)3s, versus the original MOLLI scheme 3b(3b)3b(3b)5b (9). However, the discussions 
made in this work are not specific to MOLLI or to any specific MR system manufacturer; 
whatever T1 mapping method is used, the scanning procedures used to acquire the reference 
data should be performed in the same way when obtaining subsequent clinical data. Details 
such as the heart phase used for data acquisition may be noted; in normal myocardium, 
diastolic and systolic myocardial T1 values differ but correlate strongly, and blood correction 
reduces variability and gender differences (10, 11).
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Guidelines for recording region of interest (ROI) values from T1 maps are provided in the 
2017 consensus statement (4). Where options are available, decisions should be recorded, so 
that the same approach can be mandated in subsequent diagnostic work, for example whether 
to draw an ROI on the septum only or over the whole myocardium. The mean pixel value of 
each ROI is recorded, which is used in reference range calculation. The standard deviation of 
individual ROIs would not generally be used in the calculation, but may also be recorded; if 
the standard deviations are very large or variable, it may be necessary review certain 
subjects’ data. 
The calculations which are described assume that the sample of healthy T1 values measured 
are drawn from a population which is Normally distributed. Though a Normal distribution of 
T1 values are expected, it is essential to check that the shape of the distribution of the sample 
data is consistent with a Normal distribution. It is incorrect to use the calculations below 
without preliminary verification or else an erroneous reference range might be created (5). 
Various parametric tests can be used to provide evidence that sample data are likely drawn 
from a Normally distributed population. The Shapiro- ilk test is the most accurate test for 
small sample sizes and is recommended, although a range of methods are available (12). We 
are not aware of any previous findings of non-Normal distributions of healthy myocardial T1. 
In the unexpected scenario that sample data are not Normally distributed (or cannot be made 
Normal after transformation e.g. log, power, or some other function of the original scale), 
non-parametric statistics would be required, which are not covered here. Such a finding 
would have significant implications because although it simplifies calculation of the 
reference range, many more samples (healthy subjects) would be necessary.
Outliers may be discarded for a variety of reasons (conditions of the subject, measurement 
problems etc.). Nevertheless, sometimes outliers may occur with no such obvious reason for 
their occurrence. Whilst the Normal distribution allows for extreme values, such values may 
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be removed if they are clinically implausible. Outliers can be identified from a visual 
inspection of the data, for example using the straightforward box-and-whisker plot using the 
ROI mean values (readily available in many spreadsheet applications and statistics 
packages/languages as well as online). In ambiguous cases a statistical method is useful to 
justify or rule out exclusion such as that described in this work.
A common reference range principle is to arbitrarily consider the central 95% of samples as 
being within the reference range, though adoption of a different interval may be acceptable 
with clinical justification. Here the standard 95% value is used.
The 2017 consensus statement (4) recommends calculation of the limits of the reference 
range “with the upper and lower range of normal defined by the mean plus and minus 2 
standard deviations of the normal data”. To contain 95% of all values in the population, the 
advised standard deviation multiplier of 2 is approximate, and valid only for large sample 
counts. The calculations described here provide a more accurate multiplier value using the 
Student’s t-distribution which is appropriate when the sample size is small and the whole 
population (not sample) standard deviation is unknown, as is the case in this context. Careful 
reading of normative values reported in the literature is advised; the mean plus and minus 
only one standard deviation may be reported.
A reference range is intended to characterise a population. The correct interpretation of the 
reference range can have important consequences for patient care and should be done in 
consultation with a professional statistician. A distinction should be made between such 
descriptive statistics and clinical decision thresholds. A value within a reference range may 
be “typical” but it does not indicate “healthy”. Similarly a value outside a reference range 
may be atypical but may not necessarily indicate disease. It is useful to remember that it is 
only an estimate of the true reference range which is, in general, unknowable, and hard 
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thresholds for “normal” and “abnormal” reflect our choices in calculations and not nature. 
Clinical decision thresholds are based on diagnostic questions, are defined by consensus, and 
are thresholds above or below which a specific medical decision is proposed (8). They are 
often derived from Receiver Operating Characteristic (ROC) curves and predictive values 
(13, 14). Where a reference range has wide confidence intervals around its reference range 
limits due to limited sample size, it may be prudent to use three classes of values instead of a 
standard normal/abnormal dichotomy, to manage the imprecision in the reference range limits 
(15). For example, the three classes of values may be: normal, indicating values within the 
reference range but more conservatively not including any values within the confidence 
intervals of the reference range limits (i.e. Q to P, in Figure 1); indeterminate, indicating 
values contained within the confidence intervals of the reference range limits (R to Q, and P 
to N, in Figure 1); or abnormal, indicating values outside both the reference range and the 
confidence intervals of the reference range limits (<R and >N in Figure 1, see also extremes of 
90% CIs of reference range limits in Table 2). From a health-economic perspective, an 
“indeterminate” finding represents a futile use of MRI: if the proportion of “indeterminate” 
findings is unacceptably high this may suggest that the number of subjects used to determine 
the reference range was too low. 
The number of healthy subjects, or normal individuals (referred to MR without any abnormal 
findings) required to create a reference range is not straightforward (16); it depends on the 
precision desired, which in turn depends on the proposed clinical application and diseases 
which may be encountered. Moreover, the number required also depends on the precision of 
the measurement method which varies from one method to the next (which for myocardial T1 
mapping includes variations such as patient setup, system type, sequence used, analysis steps, 
etc). However some help can be given by asking a different question: How many samples are 
needed such that the confidence intervals for the reference range limits are at most a 
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particular proportion (p, e.g. one-third) of the reference range size? In other words, a 
judgement can be made about the precision of the limits of the reference range, compared to 
the width of the reference range itself; this can be visualised with the help of Figure 1 looking 
at R to Q (or P to N) versus the reference range. We may estimate the number of samples 
needed by observing the following (cf 18E.1. in ref. 16). The standard error of the limit of the 
reference range ( , result K in Table 1) may be approximated to  where  is the  !"#$ 3%
2 & &
number of samples and  is the standard deviation. The confidence interval around the %
reference range limit is  times  where  is the critical t value (result L in Table 1), and 2'  !"#$ '
the width of the reference range is . Therefore, the proportion p which we wish to 2'%
calculate is , which reduces to . Thus, the number of samples 2' !"#$ 2'% ( = (3 &) 
required to yield an acceptable proportion of the reference range size for the confidence 
intervals of the reference range limits is  Then, for example: if the acceptable & = 3 (2.
proportion of the reference range size for the confidence intervals of the reference range 
limits is one quarter, the approximate number of samples required can be calculated using 
3/(0.25^2) = 48. 
The number of subjects required for the reference range can be related to the expected T1 of 
myocardium for specific diseases, if the width of the reference interval is known or can be 
approximately established. Similarly, the utility of an existing reference range can be 
checked. For example: if a local myocardial T1 reference range at 1.5T happens to be 940 to 
1060 ms, and in disease a hypothetical T1 of 920 ms is expected, in order to limit the 
confidence intervals of the reference interval limits to 40 ms (±(940-920)) so that a value of 
920 ms may be confidently interpreted as abnormal, the number of samples required can be 
calculated using 3/((40/(1060-940))^2) = 27.
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For diseases in which the change in myocardial T1 is small (e.g. diseases causing diffuse 
myocardial fibrosis), smaller CIs around the reference range limits are required, necessitating 
a larger sample size when creating the reference range to be able to constructively classify 
patients’ T1 values. 
There are challenges involved in harmonising reference ranges from different institutions or 
from different equipment manufacturers. However, benchmarking local data against 
published reference ranges is possible and recommended (4). The following method is 
standardised practice in biochemistry (17). Twenty subjects’ data (after removing outliers) 
are collected representing the local apparently healthy population satisfying the population 
criteria. Then, if no more than two of the 20 subjects fall outside the reference range, the 
reference range can be adopted, at least provisionally (5). If three or more are outside the 
reference range, the experiment should be repeated with another 20 subjects (after removing 
outliers). Again, if no more than two of the 20 subjects fall outside the reference range, the 
reference range can be adopted. If three or more are outside the reference range, the reference 
range is probably not valid and a local reference range should be created. This benchmarking 
verification method is valid where the population from which the reference values are 
measured has a Normal distribution. It is statistically sound; the probability of rejecting the 
reference range when in fact at least 95% of the whole local population do fall within the 
reference range being tested is 5 to 7% (17). In our 3.0T data from site 1, it can be observed 
only two data points fall outside of the 3.0T reference range from site 2, despite differences 
in: specific scanner type; heart phase of data acquisition (end systole vs end diastole, 
respectively); and ROI inclusion criteria (whole heart vs only mid-slice, respectively). Thus, 
the benchmarking of the 3.0T reference ranges from site 1 against site 2 is successful.
Reproducibility data on myocardial T1 measurement is accumulating in the literature, 
including: assessment in Fabry disease (18); inter-study, inter-observer and inter-center 
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reproducibility in hemodialysis patients (19); at different field strengths (20); evaluation of 
different T1 mapping methods (21). It is advised that regularly repeated phantom-based 
quality control is performed to periodically confirm that the status and stability of the MR 
system have not changed significantly during the time between establishing a reference range 
and clinical scanning (4). Detailed instruction on quality control in MRI including of 
relaxometry, as well as discussion on appropriate phantom design, is available (22, 23). 
A limitation of this study is the arbitrary numbers of normal subjects included from sites 1 
and 2, according to the data available at the time. These numbers are not designed to produce 
a reference range with a specific utility according to a particular clinical question. 
Nevertheless, the reference ranges created show the steps to follow and considerations to 
make, and may be used for benchmarking.
In order for imaging biomarkers to cross clinical translation gaps, validation of the imaging 
biomarker must be robust. Myocardial T1 mapping in routine clinical practice still faces 
challenges including the creation of a local reference range of values, or the validation of a 
previously established and/or external reference range at the local site. The calculations and 
discussions provided in this work will equip the reader to perform these tasks.
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Tables
Value Spreadsheet Comment Result label
Mean AVERAGE(<range>) A
Standard deviation STDEV.S(<range>) Appropriate for a sample B
Sample size COUNT(<range>) C
Degrees of freedom C-1 D
Significance level 1-0.95 One, minus proportion of 
values to be considered 
“normal”, usually 95%
E
Critical t value for 
reference interval
T.INV.2T(E,D) Two-tailed F
Reference interval 
tolerance
B*F This result is one side of 
the reference range
G
Upper limit of 95% 
reference range
A+G H
Lower limit of 95% 
reference range
A-G J
Standard error of the 
tolerance
SQRT(B^2*((1/C)+(2/(D)))) Will be used for 
confidence interval 
around reference interval 
limits
K
Critical t value for 
reference interval limits
T.INV.2T(1-0.9,D) Typically 90% CI is used L
Reference range limits 
tolerance
L*K This result is one side of 
the range-limit CI
M
Upper 90% CI limit for 
upper limit of reference 
range
H+M N
Lower 90% CI limit for 
upper limit of reference 
range
H-M P
Upper 90% CI limit for 
lower limit of reference 
range
J+M Q
Lower 90% CI limit for 
lower limit of reference 
range
J-M R
90% CI of the mean 
value
CONFIDENCE.T(1-
0.9,B,C)
Using t distribution. 
Typically 90% CI is used
S
Mean upper 90% CI 
limit
A+S T
Mean lower 90% CI 
limit
A-S U
Table 1. Series of spreadsheet calculations required for creating a reference interval and describing it. Commands are for 
Microsoft Excel 2010 or later but other tools have similar commands. For example if using Google Sheets change only 
“STDEV.S” to “STDEV”, and “CONFIDENCE.T(1-0.9,B,C)” to “T.INV.2T(1-0.9,D)*B/SQRT(C)”.
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Reference 
range (ms)
Extremes of 90% 
CIs of reference 
range limits (ms)
90% CIs of reference 
range limits as 
proportion of the 
reference range 
n (excl. 
outliers)
Site 1, 3.0T 1129 to 1301 1102 to 1328 32% 21
Site 2, 3.0T 1160 to 1309 1145 to 1323 19% 59
Site 2, 1.5T male 933 to 1020 927 to 1025 13% 130
Site 2, 1.5T female 965 to 1054 957 to 1061 18% 68
Table 2. Comparison of reference ranges.
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Figure/Table legends
Figure 1. Illustrative relationship between various calculated values. 
Figure 2. 3.0T data from both site 1 and site 2. Both data sets include males and females. 
Center lines show the medians; box limits indicate the 25th and 75th percentiles as 
determined by R software; whiskers extend 1.5 times the interquartile range from the 25th 
and 75th percentiles; no outliers are present; cross represents sample mean; data points are 
plotted as open circles. n = 21 (site 1) and n = 59 (site 2) sample points.
Figure 3. 1.5T data from site 2 only. Center lines show the medians; box limits indicate the 
25th and 75th percentiles as determined by R software; whiskers extend 1.5 times the 
interquartile range from the 25th and 75th percentiles; cross represents sample mean; data 
points are plotted as open circles. Male n = 132 (two outliers are seen) and female n = 68 
sample points.
Table 1. Series of spreadsheet calculations required for creating a reference interval and 
describing it. Commands are for Microsoft Excel 2010 or later but other tools have similar 
commands. For example if using Google Sheets change only “STDEV.S” to “STDEV”, and 
“CONFIDENCE.T(1-0.9,B,C)” to “T.INV.2T(1-0.9,D)*B/SQRT(C)”.
Table 2. Comparison of reference ranges.
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Figure 1: Illustrative relationship between various calculated values. 
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Figure 2. 3.0T data from both site 1 and site 2. Both data sets include males and females. Center lines show 
the medians; box limits indicate the 25th and 75th percentiles as determined by R software; whiskers 
extend 1.5 times the interquartile range from the 25th and 75th percentiles; no outliers are present; cross 
represents sample mean; data points are plotted as open circles. n = 21 (site 1) and n = 59 (site 2) sample 
points. 
81x57mm (300 x 300 DPI) 
Page 26 of 56
Journal of Magnetic Resonance Imaging
Journal of Magnetic Resonance Imaging
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
FO
R PEER REVIEW
 O
N
LY
 
Figure 3. 1.5T data from site 2 only. Center lines show the medians; box limits indicate the 25th and 75th 
percentiles as determined by R software; whiskers extend 1.5 times the interquartile range from the 25th 
and 75th percentiles; cross represents sample mean; data points are plotted as open circles. Male n = 132 
(two outliers are seen) and female n = 68 sample points. 
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